First published in Neuropsychiatric Disease and Treatment on 2011
Neuropsychiatr Dis Treat. 2011;7:351-6. doi: 10.2147/NDT.S18455.
Authors: Engel A, Helfrich J, Manderscheid N, Musholt PB, Forst T, Pfützner A, Dahmen N
Abstract
Background
Narcolepsy is a severe sleep-wake cycle disorder resulting in most cases from a lack of orexin, the energy balance-regulating hormone. Narcoleptic patients have been reported to suffer from an excess morbidity of Type 2 diabetes, even after correction for their often elevated body mass index.
Methods
To explore whether narcolepsy is specifically associated with a propensity to develop insulin resistance, we measured fasting glucose, insulin, and intact proinsulin levels in 43 narcoleptic patients and 47 controls matched for body mass index and age. The proinsulin-to-insulin ratio was calculated. Insulin resistance was determined using the homeostatic model assessment method.
Results
Narcoleptic patients did not show elevated insulin resistance parameters.
Conclusion
In contrast with earlier reports, we found no evidence that narcolepsy specifically elevates the risk of insulin resistance (and consequently of type 2 diabetes) independently of body mass index.
REACHING OUT IS EASY AND FAST – LET’S TALK
Prof. Dr. Thomas Forst
Chairman of the Executive Board
located at CRS Mannheim
LET’S TALK SCIENCE
Dr. Marc Hetzel
VP & Head of Business Development
located at CRS Management
LET’S TALK BUSINESS